My Team of Care: a Pilot Randomized Controlled Trial of an Online Communication Tool for Collaborative Care (Loop)

August 15, 2016 updated by: Mount Sinai Hospital, Canada

My Team of Care (MyTOC) Trial: a Pilot Randomized Controlled Trial of an Online Communication Tool (Loop) for Collaborative Care in Complex Patients

This project will pilot and test a new online communication tool, Loop, developed within a research framework with participatory and user-centred design. This pilot trial focuses on advanced cancer as an example of complex care. Cancer care involves many healthcare providers, spanning hospital to home. There is no organized way for them to communicate. Loop is a practical tool for ongoing collaboration in the patient's actual team of care that engages patients. The study will answer the questions: does Loop improve communication efficiency, engage patients and family physicians, and show early benefits in quality and health care costs?

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5T 3L9
        • Mount Sinai Hospital
      • Toronto, Ontario, Canada, M5T 2M9
        • Princess Margaret Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients with Stage IV cancer, or Patients with stage III cancer and poor prognosis as determined by a physician (>3 months but <2 years)
  2. Eastern Cooperative Oncology Group (ECOG) performance status score ≤2
  3. Each patient must have at least two healthcare providers, including an attending oncologist or palliative care physician
  4. Patient and, if applicable, family caregiver must be ≥18 years of age
  5. Literacy and language capacity and competency to provide informed consent
  6. Patient or caregiver must have access to a computer and the internet

Exclusion Criteria:

  1. Patients without the capacity to participate in use of the online tool, and do not have a caregiver who can engage in use of the tool on their behalf
  2. Participants without the capacity to participate in evaluation of outcome measures, including, but not limited to, online and paper-based multiple-choice questions, checklists, and visual analogue scales, and do not have a family caregiver who can complete outcome measures
  3. A potential candidate for or currently receiving hormone therapy for breast or prostate cancer
  4. Patients with a prognosis of <3 months as determined by attending physician
  5. Patients with impaired mental status as previously assessed by a physician or judged by research staff using the Bedside Confusion Scale
  6. It has been determined that the patient is participating in another study precluding them from taking part in this study, as determined by an agreed-upon algorithm, tracked and managed by study coordinators

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
The randomization is at the level of attending healthcare professional who identifies patients for recruitment. For each participant in the intervention arm, a secure space (called a Patient Loop) is created in the online clinical communication system. A Patient Loop can be accessed by the patient, their caregiver, and the healthcare providers who have permission to do so through an algorithm of invitation, authentication and careful partitioning. In each Patient Loop, team members can post messages that can be read and responded to by the entire team. Each Patient Loop consists of a patient, their caregiver and at least two healthcare professionals.
Loop is a secure online communication system centered on the patient that assembles the patient's actual healthcare team for ongoing collaborative care. The patient and caregiver are integral members of the team. Loop is cross-organizational, cross-setting and interprofessional. It is for ongoing, interactive, contextual, team-based communication. Loop is explicitly for asynchronous communication, not instant messaging. The stream of messages is stored and can be sorted for ease of viewing. The tool was developed with user-centred design and requires no prior training.
Other Names:
  • Online Clinical Collaboration System
  • My Team of Care (MyTOC)
No Intervention: Control Group
Participants receive usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Trial feasibility measured with number of patients recruited for study who have consented and participate for the duration of the study.
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trial feasibility measured with number of healthcare providers recruited for study who have consented and participate for the duration of the study.
Time Frame: 1 year
1 year
Trial feasibility measured with number of family caregivers recruited for study who have consented and participate for the duration of the study.
Time Frame: 1 year
1 year
Palliative Care Outcomes Scale
Time Frame: 3 months
A 12 item questionnaire measuring patient-reported quality of care
3 months
Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale
Time Frame: 3 months
An 8 item questionnaire measuring patient-perceived continuity and coordination of care
3 months
Ambulatory and Home Care Record
Time Frame: 3 months
Measure of ambulatory, home-based and acute care health services utilization, and associated public and private costs
3 months
Edmonton Symptom Assessment Scale
Time Frame: 3 months
A 10 item questionnaire measuring symptom intensity
3 months
Eastern Cooperative Oncology Group score
Time Frame: 3 months
A measure of performance status
3 months
The proportion of eligible participants who are invited to participate
Time Frame: 1 year
1 year
The proportion of invited participants who consent to participate
Time Frame: 1 year
1 year
The mean duration of participation of all study participants
Time Frame: 1 year
1 year
Instrument completion rate for the Palliative Care Outcomes Scale
Time Frame: 1 year
1 year
Item response rate for the Palliative Care Outcomes Scale
Time Frame: 1 year
1 year
Instrument completion rate for the Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale
Time Frame: 1 year
1 year
Item response rate for the Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale
Time Frame: 1 year
1 year
Instrument completion rate for the Ambulatory and Home Care Record
Time Frame: 1 year
1 year
Item response rate for the Ambulatory and Home Care Record
Time Frame: 1 year
1 year
Instrument completion rate for the Edmonton Symptom Assessment Scale
Time Frame: 1 year
1 year
Item response rate for the Edmonton Symptom Assessment Scale
Time Frame: 1 year
1 year
Number of family physicians who participate per study group
Time Frame: 1 year
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of posts per participant on the Loop system
Time Frame: 3 months
3 months
Number of times a patient logs into the Loop system
Time Frame: 3 months
3 months
Number of times a caregiver logs into the Loop system
Time Frame: 3 months
3 months
Number of times a healthcare provider logs into the Loop system
Time Frame: At end of study participation
Healthcare providers will be enrolled in the study for between 3 months and 1 year
At end of study participation
Time interval between a message posting by a patient/caregiver and a response by a healthcare provider on the Loop system
Time Frame: 3 months
3 months
Number of occurrences of user-reported errors
Time Frame: 3 months
3 months
Proportion of functions being used on the Loop system
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amna Husain, MD MPH, Temmy Latner Center for Palliative Care, Mount Sinai Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

January 26, 2015

First Submitted That Met QC Criteria

February 20, 2015

First Posted (Estimate)

February 26, 2015

Study Record Updates

Last Update Posted (Estimate)

August 16, 2016

Last Update Submitted That Met QC Criteria

August 15, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neoplasms

Clinical Trials on Loop

3
Subscribe